日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.

天然可溶性 E1E2 糖蛋白异二聚体在自组装蛋白纳米颗粒上的应用,用于丙型肝炎病毒疫苗设计。

He Linling, Lee Yi-Zong, Zhang Yi-Nan, Newby Maddy L, Janus Benjamin M, Gonzalez Fabrizio G, Ward Garrett, DesRoberts Connor, Hung Shr-Hau, Giang Erick, Allen Joel D, Kulakova Liudmila, Toth Eric A, Fuerst Thomas R, Law Mansun, Ofek Gilad, Crispin Max, Zhu Jiang

The conjugation-resistant bile acid norUDCA cures liver fibrosis but impairs systemic energy metabolism

抗结合胆汁酸norUDCA可治愈肝纤维化,但会损害全身能量代谢。

Evangelakos, Ioannis; Verkade, Esther; Rohde, Julia K; Zaufel, Alex; Vargek, Martin; Heine, Markus; Worthmann, Anna; Graute, Sebastian; Manka Fuh, Marceline; Gunasekaran, Karthikeyan; Kumari, Manju; Schwinge, Dorothee; von Bergen, Martin; Rolle-Kampczyk, Ulrike; Engelmann, Beatrice; Breinbauer, Rolf; Fuerst, Rita; Saleem, Umber; de Boer, Jan Freark; Schlein, Christian; Hansen, Arne; Scheja, Ludger; Kuipers, Folkert; Moustafa, Tarek; Heeren, Joerg

Regenerative Surgical Treatment of Peri-Implantitis: A Systematic Review and Meta-Analysis

种植体周围炎的再生外科治疗:系统评价和荟萃分析

Fuerst, Gabor; Ali, Shko Atta; Rausch-Fan, Xiaohui; Laky, Markus

mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitope

mAbClust 结合 AlphaFold 3 可避免产生幻觉,从而确定一个广谱中和 HCV 表位的四级结构。

Paul, Harry T; Mimms, Jessica L; Aboueid, Hanna; Buitrago, Laura Sanchez; Kulakova, Liudmila; Wilcox, Xander; Kuhn, Katrina; Zhang, Hao; Toth, Eric A; Skinner, Nicole; Flyak, Andrew I; Ofek, Gilad; Benjamin Larman, H; Fuerst, Thomas R; Ray, Stuart C; Cox, Andrea L; Bailey, Justin R

Engineered subtilisin protease degrades active KRAS in cancer cells, leading to differential cell targeting

经基因工程改造的枯草杆菌蛋白酶可降解癌细胞中的活性KRAS,从而实现差异化细胞靶向治疗。

Goldstein, M E; Chu, B; Carillo, K J; Orban, J; Toth, E A; Fuerst, T R

Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement risk.

黄病毒E蛋白疫苗的合理设计可优化免疫原性并降低抗体依赖性增强风险。

Wang Yimeng, Galkin Andrey, Shang Xiaoran, Marin Alexander, Jin Shaohua, Ye Ting-Juan, Bale Shridhar, Chiang Chi-I, Chowdhury Ananda, Chenine Agnes L, Turonis Ashley, Greenhouse Jack, Stone Rebecca, Wear Jaclyn, Kar Swagata, Andersen Hanne, Huang Yan-Jang S, Vanlandingham Dana L, Higgs Stephen, Lapidus Rena G, Fuerst Thomas, Weber David J, Wyatt Richard T, Iffland Christel, Pierson Theodore C, Andrianov Alexander K, Pozharski Edwin, Li Yuxing

Virus-Mimicking Polymer Nanocomplexes Co-Assembling HCV E1E2 and Core Proteins with TLR 7/8 Agonist-Synthesis, Characterization, and In Vivo Activity

病毒模拟聚合物纳米复合物与 TLR 7/8 激动剂共组装 HCV E1E2 和核心蛋白——合成、表征及体内活性

Fuerst, Thomas R; Marin, Alexander; Jeong, Sarah; Kulakova, Liudmila; Hlushko, Raman; Gorga, Katrina; Toth, Eric A; Singh, Nevil J; Andrianov, Alexander K

Cryo-EM structures of HCV E2 glycoprotein bound to neutralizing and non-neutralizing antibodies determined using bivalent Fabs as fiducial markers.

利用二价 Fab 作为参考标记,确定了 HCV E2 糖蛋白与中和抗体和非中和抗体结合的冷冻电镜结构

Shahid Salman, Karade Sharanbasappa S, Hasan S Saif, Yin Rui, Jiang Liqun, Liu Yanxin, Felbinger Nathaniel, Kulakova Liudmila, Toth Eric A, Keck Zhen-Yong, Foung Steven K H, Fuerst Thomas R, Pierce Brian G, Mariuzza Roy A

Regulation of phage therapy medicinal products: developments, challenges, and opportunities

噬菌体疗法药品监管:发展、挑战与机遇

Fuerst-Wilmes, Miriam; Respondek, Vanessa; Schramm, Michael; Lilienthal, Nils; Buss, Katrin; Duechting, Anja

Changes to the use of medicines containing the antibiotic azithromycin

含有抗生素阿奇霉素的药物使用方法发生变化

Ruepp, Robin; Botgros, Radu; Le Ber, Veronique; Brandt, Franziska; Pantke, Ellen; Fuerst-Wilmes, Miriam; Gomez-Outes, Antonio; Fernandez-Cortizo, Maria Jesus